This Week in Mental Health Technology
A quick roundup of what caught my eye this week — grouped by theme, because these stories aren’t really one story. They’re three different conversations happening at once: what the research is starting to detect, what AI can and can’t actually do, and what’s happening at the policy and access level. Here’s all three.
Where the Research Is Heading
AI is getting better at spotting depression and suicide risk before a crisis — using sweat, brain signals, and eye movements.
A new USC study is using multimodal signals — physiological data most of us wouldn’t think to measure — combined with AI to detect depression and suicide risk. It’s early, but it’s a real signal of where passive monitoring technology is headed: less about self-reported symptoms, more about the body’s own data.
One to watch: mixed-reality therapy.
A company called Aspichi is blending 360-degree VR environments with validated therapy protocols for behavioral health treatment. It’s not SMI-specific yet, but immersive therapy tools are a space worth keeping an eye on as the technology matures.
Rethinking What AI Can (and Can’t) Do
This is the conversation I keep coming back to — and it’s the same one I got into on my recent podcast appearance about technology’s role in mental health.
AI can’t replace a therapist. But it might fill in the gaps.
A piece in The Conversation makes a case I fully agree with: the value of AI in mental health isn’t in replacing human care, it’s in supporting the space between appointments — the part of the journey clinicians never see.
Keeping humans at the center of AI-supported care.
MedCity News makes a similar point from the industry side: successful AI implementation in mental healthcare depends on keeping people — not automation — at the center of the design. Worth reading alongside the piece above; they’re arguing the same thing from two different angles.
Policy and Access
SAMHSA just opened up $281 million in new funding.
The Substance Abuse and Mental Health Services Administration announced new funding opportunities aimed at addiction, overdose, and mental illness recovery. If you work with or run an advocacy organization, this is worth a look — this is exactly the kind of opportunity that can fund new programs for families navigating SMI.
Nearly a quarter of mental health providers have month-long waitlists or closed caseloads.
A new report finds 23% of mental health providers are reporting waits of four weeks or more, or caseloads that are simply closed. It’s a sobering data point — and it’s exactly the gap I keep pointing to: access to a system is not the same as access to care.
A Research Note, Just Because
Schizophrenia and bipolar disorder share 70% of their genetic roots, according to a new landmark study.
Not a technology story, but a striking one — a reminder that the lines we draw between diagnoses are often blurrier at the biological level than they are in a clinical chart.
—
That’s the roundup for this week. If any of these spark a thought or a question, hit reply — I read every one.
www.resourcesforsmi.com
be safe out there. x
